|

Validation of Hematological Indices

RECRUITINGN/ASponsored by Petrovsky National Research Centre of Surgery
Actively Recruiting
PhaseN/A
SponsorPetrovsky National Research Centre of Surgery
Started2023-06-19
Est. completion2025-11-01
Eligibility
Age18 Years – 80 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06476171

Summary

The hypothesis of the study is that hematological indices (neutrophil to lymphocyte ratio, platelet to lymphocyte ratio and systemic index of inflammation) may be predictors of infectious complications and multiple organ dysfunction in patients after cardiac surgery.

Eligibility

Age: 18 Years – 80 YearsHealthy volunteers accepted
Inclusion Criteria:

* age from 18 to 80 years
* cardiac surgery
* operation in the conditions of cardiopulmonary bypass
* availability of voluntary informed consent of the patient to participate in the study

Exclusion Criteria:

* refusal of the patient from the study
* transfer of the patient to another medical institution

Conditions5

Heart DiseaseMultiple Organ DysfunctionPneumoniaSepsisWound Infection

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.